Nifty 17196.7 (-1.18%)
Sensex 57696.46 (-1.31%)
Nifty Bank 36197.15 (-0.85%)
Nifty IT 35848.05 (-0.86%)
Nifty Financial Services 17779.5 (-1.13%)
Adani Ports 737.45 (-0.22%)
Asian Paints 3110.45 (-2.21%)
Axis Bank 673.00 (-0.46%)
B P C L 385.90 (1.86%)
Bajaj Auto 3287.85 (-1.22%)
Bajaj Finance 7069.25 (-1.55%)
Bajaj Finserv 17488.70 (-1.52%)
Bharti Airtel 718.35 (-1.94%)
Britannia Inds. 3553.75 (-0.69%)
Cipla 912.05 (-1.00%)
Coal India 159.75 (0.28%)
Divis Lab. 4757.05 (-0.42%)
Dr Reddys Labs 4596.50 (-1.42%)
Eicher Motors 2455.55 (0.16%)
Grasim Inds 1703.90 (-1.16%)
H D F C 2771.65 (-1.29%)
HCL Technologies 1171.40 (-1.12%)
HDFC Bank 1513.55 (-0.80%)
HDFC Life Insur. 690.95 (-2.03%)
Hero Motocorp 2462.45 (-0.41%)
Hind. Unilever 2343.65 (-1.66%)
Hindalco Inds. 424.65 (-1.72%)
I O C L 122.20 (1.28%)
ICICI Bank 716.30 (-0.84%)
IndusInd Bank 951.15 (0.59%)
Infosys 1735.55 (-0.73%)
ITC 221.65 (-1.69%)
JSW Steel 644.55 (-0.34%)
Kotak Mah. Bank 1914.20 (-2.55%)
Larsen & Toubro 1801.25 (0.67%)
M & M 836.95 (-1.48%)
Maruti Suzuki 7208.70 (-1.59%)
Nestle India 19321.35 (-0.93%)
NTPC 127.00 (-1.32%)
O N G C 145.90 (1.32%)
Power Grid Corpn 206.10 (-3.92%)
Reliance Industr 2408.25 (-3.00%)
SBI Life Insuran 1165.95 (-1.86%)
Shree Cement 25914.05 (-1.43%)
St Bk of India 473.15 (-0.81%)
Sun Pharma.Inds. 751.80 (-1.89%)
Tata Consumer 774.30 (0.14%)
Tata Motors 480.10 (0.21%)
Tata Steel 1118.00 (0.50%)
TCS 3640.45 (-0.07%)
Tech Mahindra 1593.30 (-2.23%)
Titan Company 2369.25 (-0.72%)
UltraTech Cem. 7332.45 (0.13%)
UPL 712.75 (2.08%)
Wipro 640.75 (-0.94%)

Penny Stock Update: These stocks gained up to 10.00% on Monday

Penny Stock Update: These stocks gained up to 10.00% on Monday
by 5paisa Research Team 15/11/2021

On Monday, the Indian equity market was volatile. BSE Healthcare index is the top gainer whereas BSE Metal index is the top loser in today’s trade.

On the first trading day of the week, the Indian equity market was volatile.

Today Nifty 50 and BSE Sensex indices closed in positive, up by 6.70 points i.e., 0.04% and 32.02 points i.e., 0.05% respectively. Stocks pulling the BSE Sensex index up was Power Grid Corp, Asian Paints, Kotak Mahindra, ITC and TCS. Whereas, stocks that dragged the BSE Sensex down is Reliance Industries, Tata Steel, Bajaj Finance, ICICI Bank and Bajaj Finserv. After the weekend, on Monday the BSE Sensex index opened up by 0.25% from the previous close. Besides, the day high of the index was 61,036.56 and the day low was 60,597.36.

In Monday's trading session the S&P BSE Healthcare, S&P BSE MidCap Select Index, S&P BSE Fast Moving Consumer Goods and S&P BSE SmallCap Select Index were top gainers. BSE Healthcare index consisting of stocks such as Apollo Hospitals Enterprise Ltd, Laurus Labs Ltd, Metropolis Healthcare Ltd and Fortis Healthcare Ltd are the top gainers.

On a sectoral basis, S&P BSE Metal, S&P BSE Basic Materials, S&P BSE Enhanced Value Index and S&P BSE Telecom were top losers. BSE Metal consists of stocks such as Coal India Ltd, Tata Steel Ltd, Hindalco Industries Ltd and Jindal Steel & Power Ltd.

Here is the list of penny stock that gained up to 10.00% on a closing basis on Monday, November 15, 2021:

Sr No.               

Stock               

LTP                

Price Gain%               

1.               

Manugraph India Ltd.  

13.90  

9.88  

2.               

Sel Manufacturing Company Ltd  

8.90  

9.88  

3.               

IMP Powers Ltd  

13.10  

9.62  

4.               

MSP Steel & Power Ltd  

9.75  

9.55  

5.               

JIK Industries Ltd  

0.75  

7.14  

6.               

Shekhawati Poly-Yarn Ltd  

0.75  

7.14  

7.               

Bharatiya Global Infomedia Ltd  

3.15  

5.00  

8.               

Grand Foundry Ltd  

3.15  

5.00  

9.               

Indowind Energy Ltd  

13.65  

5.00  

10.               

Sab Events & Governance Ltd  

4.20  

5.00  

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

ONGC Q2 reported revenue up by 6% QoQ basis. Skyrocketing Brent prices and severe winter may cause a setback in near term

by 5paisa Research Team 15/11/2021

ONGC reported revenue of Rs. 243.5b, 6%, at US $69.4/bbl. The gas sales stood at 4.3bcm, down 7% YoY however up by 4% QoQ. The oil sales stood at 5mmt, down by -1% YoY and -2% QoQ. The net realization stood at USD69.4/bbl, up by +6% QoQ. VAP sales stood at 777tmt, down 7% YoY and 1% QoQ. while EBITDA stood at Rs. 132bn which was up 57% YoY and 9% QoQ.

The downside in oil and gas production was mainly on account of the unruly conditions caused by cyclone Tauktae and the impact of COVID. Further delay in the mobilization of MOPU to the WO-16 Cluster project impacted production from this field.
 
International travel restrictions and COVID Impact has led to delay in gas production and logistics from the KG Basin. The peak production is expected at 14.5mmscmd and 45kbopd for gas and oil. OPAL’s performance is steady, and ONGC is improving process efficiencies to keep its profits positive. ONGC’s profits are also supported by a positive uptrend in Brent prices, led by the gas to oil switch, creating additional demand of 0.5mnbopd, with continued lower supply from OPEC+ with production cuts still at ~4mnbopd, resulting in inventory draws. As a result, the management has revised down its oil and gas guidance for FY22E to 22mmt and 22bcm from 23mmt and 25bcm earlier. Despite the continued delay and modest assumptions, ONGC’s gas production is likely to clock in at a CAGR of 7% over FY21–24E, with efforts to resist a decline in oil production. 

The expectation of a severe winter, coupled with supply constraints and lower inventory, has led to gas prices at international hubs trading at multi year highs The estimated normalization of Brent prices by endFY22 and build in assumptions of US $69/bbl, USD65/bbl, and US $60/bbl for FY22E, FY23E and FY24E.

An interim dividend of Rs. 5.5/share has been announced, which makes its dividend yield come upto 3.5% at CMP. Lower depreciation and higher other income resulted in PBT coming in around 18% 5b. The company realized the option of the new tax regime and recorded deferred tax benefit of INR98.5b during the quarter. Reported PAT came in at Rs. 183.5b, while adj. PAT for taxation stood at Rs. 85b (v/s Rs. 43b in 1QFY22 and Rs. 36b in 2QFY21). Capex guidance for FY22 remains unchanged at Rs. 295b.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

F&O Cues: Key support and resistance levels for Nifty 50

F&O Cues: Key support and resistance levels for Nifty 50
by 5paisa Research Team 15/11/2021

Today the Nifty F&O action for November 18 expiry shows resistance has come down to 18,200. 

Indian equity market after showing a promising upside on Friday (November 12), failed to maintain its momentum. Nifty 50 after witnessing a gap-up opening, failed to build on that and lost all the gain in today’s trade and saw a flat closing in today’s trade. The advance-decline ratio was in favour of decline. Overall, we see there is a lack of enthusiasm among investors as they are not very clear about the market direction.

Activity in the F&O market for the weekly expiry on November 18, 2021, shows that after today’s trade, resistance has moved from 18,500 to 18,200 now. The highest call option open interest (106646) for Nifty 50 stood at a strike price of 18,200. In terms of the highest addition of open interest in the call options front, it was at 18,200 in the last trading session. A total of 57,012 open interest was added at this strike price. The next highest call option open interest stands at 18,500 where total open interest stood at 105,486.

In terms of put activity, the highest put writing was seen at a strike price of 18200 (27,124 open interest added on November 15), followed by 18,100 (19,771 open interest added on November 15). The highest put open interest unwinding was seen at a strike price of 18,000 (23,640 open interest shed on November 15). This means traders are not sure of holding the 18,000 mark for this expiry.

Highest total put open interest (81156) stood at a strike price of 18,000. This is followed by a strike price of 17,500, which saw a total put option open interest of 74,599 contracts.

Following table shows the difference between call and put options at strike price near to max pain of 18100.

Strike Price  

Open Interest (Call option)  

Open Interest (Put option)  

Diff(Put – Call)  

17,800.00  

7310  

54450  

47140  

17,900.00  

12002  

66660  

54658  

18,000.00  

33782  

81156  

47374  

18100  

67134  

49752  

-17382  

18,200.00  

106646  

35937  

-70709  

18,300.00  

90639  

6789  

-83850  

18,400.00  

65223  

2058  

-63165  

The Nifty 50 put call ratio (PCR) closed at 0.8 compared to 1.05  in the previous trading session. A PCR above 1 is considered bullish while a PCR below 1 is considered bearish.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Chart Busters: Top trading set-ups to watch out for Tuesday

Chart Busters: Top trading set-ups to watch out for Tuesday
by 5paisa Research Team 16/11/2021

On Monday, the benchmark index, Nifty has opened with an upside gap and marked the high of 18210.15 level. Thereafter, the index has lost nearly 120 points from the day high. The price action has formed a bearish candle with an upper shadow. The advance-decline ratio was in the favour of decliners.

Here are the top trading set-ups to watch out for Tuesday. 

Finolex Cables: The stock has formed a doji candlestick pattern as of July 14, 2021, and thereafter witnessed correction. During the correction, the stock has formed lower tops and almost similar bottoms. The correction is halted in between 50% to 61.8% Fibonacci retracement level of its prior upward move and it coincides with the 34-week EMA level.

On Monday, the stock has given a downward sloping trendline resistance breakout on the daily chart. This breakout was confirmed by nearly 10 times of 50-days average volume, indicating strong buying interest by market participants. The 50-days average volume was 2.49 lakh while on Monday stock has registered a total volume of 24.79 lakh. Additionally, the stock has formed an opening bullish marubozu candlestick pattern on breakout day, which indicates extreme bullishness.

The stock's Relative Strength Index (RSI) has reached its highest value in the last 14-days, which is bullish. Also, it has surged above its prior swing high. The weekly RSI has also surged above the 60 mark.
 

Technically, all the factors are currently aligned in support of the bulls. Hence, we would advise the traders to be with a bullish bias. On the upside, the prior swing high of Rs 557.70 will act as resistance for the stock.

Pearl Global Industries: The stock has formed a long-legged doji candlestick pattern as of August 03, 2021, and thereafter witnessed correction along with low volume. The correction is halted near the 61.8% Fibonacci retracement level of its prior upward move (Rs 174.10-Rs 474.70) and it coincides with the 20-day EMA level. Since the last 55 trading sessions, the stock has formed a strong base near the support zone. During the formation of the base, the volume was mostly below the 50-day average volume.

On Monday, the stock has given downward sloping trendline breakout on the daily chart. The robust volume on breakout day is portraying an encouraging picture. Mansfield Relative Strength indicator is just bouncing from the zero line and showing the outperformance compared to the broader market index i.e. Nifty-500.

Along with this breakout, the stock has surged above its short-term moving averages, i.e. 20-day EMA and 50-day EMA. The short-term moving averages are started edging higher, which is a bullish sign. The leading indicator, 14-period daily RSI surged above the 60 mark for the first time after 65 trading sessions. On the weekly chart, the RSI has given a positive crossover.

Based on the above observations, we expect the stock to continue its upward movement and test levels of Rs 356 followed by Rs 379 in the medium-term. On the downside, the 20-day EMA will act as strong support for the stock.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

There’s no stopping in this multibagger smallcap pharmaceutical stock!

There’s no stopping in this multibagger smallcap pharmaceutical stock!
by 5paisa Research Team 16/11/2021

Lyka Labs maintains high quality and GMP/GLP standards in the manufacturing and testing of its products. The company manufactures pharmaceutical products such as Dry Powder, Liquid and Lyophilised Injections and external preparations and cosmetics covering various therapeutic areas. The company is also engaged in manufacturing on a P2P basis and job work basis for Covid 19 medicines.

The company’s R&D centre is engaged in the development of new formulations and has successfully developed several products in the following product categories: 1. Injectables- Liquid Injections, Lyophilised Injections in anti-bacterial, antifungal, NSAIDS, Proton Pump Inhibitors and Anaesthetics. 2. Topical preparations: Ointments/Creams and Lotions. 

The company is also modernizing its existing manufacturing facilities to improve throughput and reduce manufacturing costs thereby increasing profitability.

To meet the increase in demand for lyophilised products the company has embarked on an expansion project of its Lyophilization Plant at its Ankleshwar factory. This project is likely to be completed in 9-12 months with a 50% capacity enhancement for lyophilisation. The company has received permission to manufacture and marketing of Liposomal Amphotericin B Injection 50 mg/vial from the Government of India, Directorate General of Health Services, New Delhi.

Interestingly, the stock has lately caught the eyes of market participants and it is quite evident from the price movement. The stock is locked at an upper circuit at the time of writing this article and it has marked a fresh 52-week high on Tuesday.

The stock has recorded over a 10-fold jump in its price from the March 2020 lows to the high of Tuesday. On an MTD basis also it has outperformed the headline indices and jumped more than 20%. The stock has a Price Strength (RS Rating) of 94 which is great indicating the outperformance as compared to other stocks. However, despite this outperformance, what is more intriguing is the fact that the stock has recently witnessed a breakout of the stage-4 consolidation pattern, the depth of which is nearly 35%.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Explained: All you want to know about the RBI’s RDS scheme for retail investors

by 5paisa Research Team 16/11/2021

Last week, Prime Minister Narendra Modi inaugurated the so-called Retail Direct Scheme (RDS) of the Reserve Bank of India (RBI) which allows retail investors to invest in government securities, or G-secs. 

The new scheme will let common people invest in G-Secs by directly opening an account with the RBI. This can be done via a new platform called the RBI-RD, which the central bank has launched. 

What sort of securities will the new platform allow people to invest in?

The RBI-RD platform will let people invest and trade in government of India treasury bills (T-bills), government of India dated securities, sovereign gold bonds and state development loans. 

What is the USP of the new scheme? 

The scheme not only offers a simple and easy process to invest in G-Secs, but also puts India in an exclusive club of nations that actually allow democratisation of government debt.

Until now, government paper has been accessible only to financial institutions which trade and invest in high volumes and have extremely high minimum threshold limits of investment.  

So, how can a retail investor actually invest in G-Secs via the new scheme?

To invest in G-Secs, a retail investor needs to open a Gilt account on the RBI-RD portal. This portal also allows people to bid in primary auctions and trade securities in the secondary market. 

How much would the new scheme cost an investor? How can money be remitted?

The new scheme allows people to invest free of charge. Customers can pay for buying G-Secs via internet banking and UPI. 

Will investors get a helpline?

Yes, investors can avail of support via the online portal, on email and on phone. 

But couldn’t small retail investors access G-Secs before this scheme came into vogue?

They could, but not directly. Such securities could only be bought via gilt mutual funds or G-Sec dealers, who participated in the central bank’s primary market auction every Friday. Moreover, existing securities could be traded on the National Stock Exchange and the Bombay Stock Exchange. 

How could the RBI attract more people to avail of the new scheme?

Experts say that one way of attracting new people to participate in the new scheme is by offering tax sops. This, they say could also attract global fintech companies who would want to provide such services in India. 

“If retail taxation of direct debt investments is brought in line with investing through debt funds, we should see some retail interest emerging,” a report by The Economic Times newspaper cited Ananth Narayan, associate professor at SP Jain Institute of Management and Research as saying.

“This could, in turn, attract intermediaries including global and local fintech companies. Also currently, small savings schemes offer much higher rates than GoI securities,” Narayan said.

What are the key challenges facing the new scheme?

For one, retail investors are unaware of G-Secs and how they work, and how investing in such instruments could be beneficial for them. Investors are also not aware of which type of G-Sec they should choose. This is especially true for high-income investors, as the interest on these instruments is fully taxable, as against debt funds like corporate bond funds and gilt funds where an investor can take the benefit of lower tax rates and indexation.  

Another possible problem could be low liquidity, which could hamper trades. The central bank may need to infuse some much-needed liquidity into these instruments, which are otherwise some of the safest vehicles for parking money and taking out steady returns over long periods of time. 

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order